Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
暂无分享,去创建一个
M. Isobe | Yoshiya Tanaka | Y. Nakaoka | N. Nishimoto | T. Ishii | S. Takei | S. Yokota | Akira Nomura | Seitaro Yoshida